.svg){kind=small}
Market Insights Snapshot
In June 2026, The Pharm’s mix split concentrated in Flower at 52.7% share (ranked 4th in Arizona Flower) versus 47.3% in Pre-Roll, but the momentum vectors diverged: Flower expanded 111.9% month over month despite only 44.1% year-over-year growth, while Pre-Roll added just 2.0% month over month on a 138.9% year-over-year base. With average price down 5.4% year over year against overall brand sales up 76.0% year over year, the mix shift toward lower-priced Flower (average $18.93) alongside steadier Pre-Roll (average $22.59) indicates volume-led gains rather than pure pricing. The pattern implies The Pharm is leaning into scale in Flower to capture June 2026 demand spikes while keeping Pre-Roll as a stable second pillar, positioning the brand to monetize traffic even as unit pricing softens.
The acceleration of Flower’s month-over-month growth rate by 109.9 percentage points over Pre-Roll, paired with a narrow 5.4 percentage-point share gap, suggests The Pharm is prioritizing shelf and production allocation to Flower to defend and potentially improve a number 4 rank in Arizona. Because Pre-Roll’s 138.9% year-over-year growth outpaced Flower’s 44.1% yet did not translate into month-over-month share gains, the brand’s near-term positioning favors fast-turn Flower velocity to drive basket penetration, while Pre-Roll functions as a price-mix buffer at a roughly 19.3% higher average price than Flower. The implication is a barbell: protect rank and traffic via Flower volume while preserving margin through steady Pre-Roll, with June 2026 execution tuned more toward velocity than premiumization.
Competitive Landscape
The Pharm is ranked #4 in AZ Flower in June 2026, improving 1 position from #5 year over year and jumping 6 positions from #10 in March 2026 to a peak of #4 in June 2026, while Just Flower held at #1 year over year and Mohave Cannabis Co. stayed at #3 despite a -13.9% sales change; in contrast, Brown Bag advanced from #7 to #5 with 72.8% YoY sales growth, tightening pressure from below. The mix of a 1-rank YoY rise and a 6-rank quarter-over-quarter climb implies The Pharm’s gains are driven by recent velocity rather than entrenched share, signaling a near-term window to consolidate position before fast-rising challengers compress the #4–#5 gap.
Notable Products
Dusties - Sapphire Infused Pre-Roll 6-Pack (3.6g) led with rank 1 but slid by 8.4% month over month while Dusties - Ruby Infused Pre-Roll 6-Pack (3.6g) at rank 4 dipped 2.8%, whereas Dusties - Emerald Infused Pre-Roll 6-Pack (3.6g) at rank 3 grew 5.5%. Four of the top ten are Pre-Roll SKUs, and two of those sit in the top 4 ranks, indicating that infused formats anchor share even as the flagship softens. Las Vegas Triangle Kush (4g) in Flower rose 3.5% at rank 8 while Dusties - Emerald Diamond Infused Pre-Roll (1.3g) jumped 23.6% at rank 10, suggesting momentum is accruing to value-sized and diamond-infused variants at the lower end of the top 10. The mix points to The Pharm leaning into an infused Pre-Roll portfolio with tiered price/size architecture, using Emerald and diamond extensions to offset softness in the Sapphire lead SKU and to widen entry points for shoppers.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
